Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance

[1]  A. Sawa,et al.  Influence of poly(I:C) variability on thermoregulation, immune responses and pregnancy outcomes in mouse models of maternal immune activation , 2019, Brain, Behavior, and Immunity.

[2]  P. Pfluger,et al.  Profound weight loss induces reactive astrogliosis in the arcuate nucleus of obese mice , 2019, Molecular metabolism.

[3]  D. Popkin,et al.  A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice , 2018, Scientific Reports.

[4]  David J. Dowling.  Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants , 2018, ImmunoHorizons.

[5]  J. Cavanagh,et al.  The Systemic Response to Topical Aldara Treatment is Mediated Through Direct TLR7 Stimulation as Imiquimod Enters the Circulation , 2017, Scientific Reports.

[6]  L. Reis,et al.  Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette‐Guérin Downregulation of Nonmuscle‐invasive Bladder Cancer , 2017, Clinical genitourinary cancer.

[7]  Gordon J. Freeman,et al.  T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity , 2017, Nature Communications.

[8]  Wang Li,et al.  Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model , 2017, Journal of Cancer.

[9]  M. Bauer,et al.  Metabolic Adaptation Establishes Disease Tolerance to Sepsis , 2017, Cell.

[10]  F. Crews,et al.  Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7 , 2017, Journal of Neuroinflammation.

[11]  D. Marks,et al.  A distinct brain pathway links viral RNA exposure to sickness behavior , 2016, Scientific Reports.

[12]  D. Marks,et al.  The central role of hypothalamic inflammation in the acute illness response and cachexia. , 2016, Seminars in cell & developmental biology.

[13]  D. Jacoby,et al.  Toll-Like Receptor 7-Targeted Therapy in Respiratory Disease , 2016, Transfusion Medicine and Hemotherapy.

[14]  K. To,et al.  Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial. , 2016, The Lancet. Infectious diseases.

[15]  Yun-Fen Hung,et al.  The microRNAs Let7c and miR21 are recognized by neuronal Toll-like receptor 7 to restrict dendritic growth of neurons , 2015, Experimental Neurology.

[16]  Sky W. Brubaker,et al.  Innate immune pattern recognition: a cell biological perspective. , 2015, Annual review of immunology.

[17]  Adam Linder,et al.  An Endotoxin Tolerance Signature Predicts Sepsis and Organ Dysfunction at Initial Clinical Presentation , 2014, EBioMedicine.

[18]  Joshua A. Kulas,et al.  A novel cell line from spontaneously immortalized murine microglia , 2014, Journal of Neuroscience Methods.

[19]  C. Croce,et al.  Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7 , 2014, Proceedings of the National Academy of Sciences.

[20]  S. Sano,et al.  Epicutaneous Application of Toll‐like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild‐Type Mice: A New Model of Systemic Lupus Erythematosus , 2014, Arthritis & rheumatology.

[21]  Joonsoo Kang,et al.  Immunological Genome Project and systems immunology. , 2013, Trends in immunology.

[22]  X. Chen,et al.  microRNAs are ligands of Toll-like receptors. , 2013, RNA.

[23]  C. Croce,et al.  A new role for microRNAs, as ligands of Toll-like receptors , 2013, RNA biology.

[24]  Atsuo Ochi,et al.  Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. , 2012, The Journal of clinical investigation.

[25]  J. Cervantes,et al.  TLR8: the forgotten relative revindicated , 2012, Cellular and Molecular Immunology.

[26]  S. Lehnardt,et al.  Extracellularly Delivered Single-Stranded Viral RNA Causes Neurodegeneration Dependent on TLR7 , 2012, The Journal of Immunology.

[27]  Mark R. Prausnitz,et al.  Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine , 2012, PloS one.

[28]  R. Malenka,et al.  An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration , 2012, Nature Neuroscience.

[29]  Ruslan Medzhitov,et al.  Disease Tolerance as a Defense Strategy , 2012, Science.

[30]  J. Roth,et al.  Fever, sickness behavior, and expression of inflammatory genes in the hypothalamus after systemic and localized subcutaneous stimulation of rats with the toll-like receptor 7 agonist imiquimod , 2012, Neuroscience.

[31]  R. Marc,et al.  Proliferative reactive gliosis is compatible with glial metabolic support and neuronal function , 2011, BMC Neuroscience.

[32]  D. Marks,et al.  Inflammation-Induced Lethargy Is Mediated by Suppression of Orexin Neuron Activity , 2011, The Journal of Neuroscience.

[33]  S. Akira,et al.  Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. , 2011, Immunity.

[34]  G. Superti-Furga,et al.  CD14 is a coreceptor of Toll-like receptors 7 and 9 , 2010, The Journal of experimental medicine.

[35]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[36]  T. van der Poll,et al.  Bench-to-bedside review: Bacterial pneumonia with influenza - pathogenesis and clinical implications , 2010, Critical care.

[37]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[38]  D. Marks,et al.  Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130. , 2010, Endocrinology.

[39]  K. Messer,et al.  Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[40]  M. Schön.  TLR7 and TLR8 as targets in cancer therapy , 2008, Oncogene.

[41]  J. Ward,et al.  Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. , 2007, Immunity.

[42]  R. Dantzer,et al.  Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .

[43]  R. Dummer,et al.  Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. , 2004, Archives of dermatology.

[44]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[45]  Michael H. Smith,et al.  Randomized, Single-Blind, Placebo-Controlled Study of Topical Application of the Immune Response Modulator Resiquimod in Healthy Adults , 2003, Antimicrobial Agents and Chemotherapy.

[46]  S. Rees,et al.  White Matter Injury after Repeated Endotoxin Exposure in the Preterm Ovine Fetus , 2002, Pediatric Research.

[47]  S. Akira,et al.  A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. , 2002, International immunology.

[48]  H. Wagner,et al.  Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 , 2002, Nature Immunology.

[49]  S. Kalra,et al.  Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods , 2002, Peptides.

[50]  K. Abe,et al.  Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. , 1991, Cancer research.

[51]  D. Remick,et al.  Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression. , 1990, The American journal of pathology.

[52]  H. Williams,et al.  Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. , 2014, The Lancet. Oncology.